Home

Press Releases

12345678910
First Farmers and Merchants Corporation Reports First Quarter Net Income up 30.5% to $4.5 Million
First Farmers and Merchants Corporation (OTC Pink: FFMH), the holding company for First Farmers and Merchants Bank, today announced its results for the first quarter of 2025.
Clasp Therapeutics Doses First Patient in Phase 1 Clinical Trial With a First-in-Class T-Cell Engager Designed to Target Cancer Cells With Absolute Specificity
Clasp Therapeutics, a biotechnology company bringing unparalleled precision to immuno-oncology using next-generation T-cell engagers (TCEs), today announced dosing of the initial patient in the GUARDIAN-101 phase 1 trial of CLSP-1025, the first tumor-specific TCE to enter clinical development. CLSP-1025 exclusively targets cancer cells expressing the p53R175H mutation, a mutation associated with a wide range of solid tumors, including colorectal, pancreatic, lung, gastric, esophageal, gynecological, and prostate cancers.
By Clasp Therapeutics · Via Business Wire · April 28, 2025
Graylog Removes Barriers to SIEM to Deliver Uncompromised Security Operations
Graylog, the no-nonsense platform for Security, API protection, and IT Operations, today launched its Spring 2025 release of Graylog Security—pushing further past the limits of traditional SIEM. Building on the Fall 2024 release (version 6.1), Graylog sharpens analyst workflows, accelerates time-to-value, and sets a new bar for speed and flexibility in threat detection.
By Graylog · Via Business Wire · April 28, 2025
Hamilton Gold Group Reviews: Products, Fees, Gold IRA, and More (Guide Released)
WireDaily has released a new guide on Hamilton Gold Group Reviews and Complaints for consumers.
Via ACCESS Newswire · April 28, 2025
Monetary Gold Review: Products, Fees, Gold IRA, and More Analyzed (Guide Released)
WireDaily has published a new analysis on Monetary Gold's reviews and complaints for 2025.
Via ACCESS Newswire · April 28, 2025
Hong Kong International Licensing Show and Asian Licensing Conference Open Today
By HKTDC · Via ACN Newswire · April 28, 2025
Ziff Davis to Participate in One Investor Conference in May
Ziff Davis, Inc. (NASDAQ: ZD) today announced its participation in one investor conference in May.
By Ziff Davis, Inc. · Via Business Wire · April 28, 2025
H Partners Files Definitive Proxy and Sends Letter to Harley-Davidson Shareholders Highlighting Urgent Need to Hold Entrenched Directors Accountable
H Partners Management, LLC (“H Partners” or “we”), one of the largest shareholders of Harley-Davidson, Inc. (NYSE: HOG) (“Harley-Davidson” or the “Company”), which beneficially owns approximately 9.1% of the outstanding shares of the Company, today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its campaign to urge shareholders to vote “WITHHOLD” on the election of three long-tenured incumbent directors – CEO and Chairman Jochen Zeitz, Presiding Director Thomas Linebarger, and 29-year director Sara Levinson – at the Company’s 2025 Annual Meeting of Shareholders (the “Annual Meeting”) scheduled for May 14, 2025.
By H Partners Management, LLC · Via Business Wire · April 28, 2025
AAVantgarde appoints Mr. Rasmus Holm-Jorgensen as Chief Financial Officer
MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector platforms for large gene delivery, today announced the appointment of Mr. Rasmus Holm-Jorgesen as their Chief Financial Officer (CFO). Rasmus brings over 25 years of experience in strategy, finance and global operations within the biopharmaceutical industry to AAVantgarde and has joined the Company’s leadership team, reporting to Dr Natalia Misciattelli, Chief Executive Officer.
By AAVantgarde · Via GlobeNewswire · April 28, 2025
Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
WATERTOWN, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including two clinical-stage programs, today announced that it will host a conference call and live webcast at 4:30 p.m. ET on Monday, May 12, 2025 to report its first quarter 2025 financial results and provide a business update.
By Neumora Therapeutics, Inc. · Via GlobeNewswire · April 28, 2025
AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
LONDON and PHOENIX, Ariz., April 28, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, and EmeritusDX, a rapidly growing cancer diagnostics and information company, are pleased to announce the expansion of their strategic partnership to include the commercialization of the MSC test for lung cancer screening. This collaboration aims to enhance the accuracy of lung nodule stratification identified via low-dose computed tomography (LDCT), thereby improving patient outcomes and reducing healthcare costs.
By AccuStem Sciences, Inc. · Via GlobeNewswire · April 28, 2025
Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates
All financial results are reported in Canadian dollars, unless otherwise stated.
By Cannara Biotech (Québec) Inc. · Via GlobeNewswire · April 28, 2025
Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combined with Lisaftoclax
ROCKVILLE, Md. and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for hematological malignancies, today announced that it has presented results from five preclinical studies during poster presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago, Illinois, USA.
Lungpacer to Showcase the Potential of Novel Technologies to Improve Lung, Heart, and Brain Health in Ventilated Patients
EXTON, Pa., April 28, 2025 (GLOBE NEWSWIRE) -- This spring, Lungpacer Medical clinical experts and device innovators will be featured presenters at top industry events. Speakers will demonstrate how novel interventional therapies can free critically ill patients from mechanical ventilation and may help improve lung, heart, and brain health in ventilated patients.
By Lungpacer Medical USA Inc. · Via GlobeNewswire · April 28, 2025
Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting
FAP-EXd (AVA6103) demonstrates tumor growth inhibition and durable complete responses in multiple therapy-resistant preclinical models
By AVACTA GROUP PLC · Via GlobeNewswire · April 28, 2025
Ampersand Biomedicines Presents Preclinical Data on AMP-410, a Novel Anti-VEGF/4-1BB Bifunctional AND-Body™ Therapeutic, at AACR 2025
Lead development candidate, AMP-410, leverages proprietary Ampersand technology to block VEGF and allosterically activate 4-1BB signaling – unlike traditional bispecific molecules – driving both adaptive and innate anti-tumor activity
By Ampersand Biomedicines · Via GlobeNewswire · April 28, 2025
DecisionDx®-Melanoma Test Ordered More Than 200,000 Times for Patients Diagnosed with Cutaneous Melanoma
FRIENDSWOOD, Texas, April 28, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its achievement of surpassing a significant milestone of 200,000 DecisionDx-Melanoma clinical test orders. DecisionDx-Melanoma is a 31-gene expression profile test that provides comprehensive, personalized results designed to improve risk-aligned management decisions for patients with stage I-III cutaneous melanoma.
By Castle Biosciences, Inc. · Via GlobeNewswire · April 28, 2025
Prairie Operating Co. Begins Completion of the Opal Coalbank Pad, Acquired from Bayswater
Opal Coalbank consists of nine DUC wells on track for production this summer
By Prairie Operating Co. · Via GlobeNewswire · April 28, 2025
Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its first quarter 2025 financial results and provide a business update on Monday, May 5, 2025.
By Syndax Pharmaceuticals, Inc. · Via GlobeNewswire · April 28, 2025
Osisko Development Announces Optimized Feasibility Study for Permitted Cariboo Gold Project with C$943 Million After-Tax NPV5% and 22.1% IRR at US$2,400/oz Base Case Gold Price; at US$3,300/oz Spot Gold C$2.1 Billion After-Tax NPV5% and 38.0% IRR
(All dollar amounts are expressed in CAD dollars, unless stated otherwise)
By Osisko Development Corp. · Via GlobeNewswire · April 28, 2025
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
Approval Supports Revenue Growth and Margin Expansion Opportunity, and Substantially Increases Peak Production Output Capacity
By ADMA Biologics, Inc. · Via GlobeNewswire · April 28, 2025
Widmer Brothers Brewing Celebrates 40th Anniversary
Portland Brewery Marks Four Decades of Widmer Beer with ‘40 Years of Cheers’ and Re-release of Four Iconic Brews
By Tilray Brands, Inc. · Via GlobeNewswire · April 28, 2025
Beamr to Participate in Upcoming Investor Conferences in May 2025
Beamr will present at the Ladenburg Thalmann Technology Innovation Expo in New York, and participate virtually in the Needham 1x1 Conference Herzliya, Israel, April 28, 2025 (GLOBE NEWSWIRE) -- Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today announced the Company will participate in the following investor conferences:
By Beamr Imaging Ltd. · Via GlobeNewswire · April 28, 2025
Auron Presents Preclinical Data Highlighting the Activity of AUTX-703 in Prostate Cancer at 2025 AACR Annual Meeting
NEWTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced preclinical data in prostate cancer at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, IL.
By Auron Therapeutics Inc. · Via GlobeNewswire · April 28, 2025
ScottsMiracle-Gro CEO Reports Strong POS Unit Gains During CNBC Mad Money Appearance
MARYSVILLE, Ohio, April 28, 2025 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the world’s leading marketer of branded consumer lawn and garden products as well as a leader in indoor and hydroponic growing products, reported that Chairman and CEO Jim Hagedorn announced during an April 25 appearance on CNBC Mad Money that the Company is driving strong consumer takeaway in the run-up to the peak lawn and garden season.
Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 on the Potential of its CDK2-directed Molecular Glue Degrader to Treat HR-positive/HER2-negative Breast Cancer
CDK2 molecular glue degrader (MGD) in combination with CDK4/6 inhibition and anti-estrogen therapy achieved superior tumor regression in vivo compared to standard of care CDK4/6 inhibition and anti-estrogen therapy
By Monte Rosa Therapeutics, Inc. · Via GlobeNewswire · April 28, 2025
Green Thumb to Open RISE Dispensary Ocala in Florida, its 104th Retail Location in the Nation, on April 29
CHICAGO and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced that RISE Dispensary Ocala, the Company’s 22nd retail location in Florida and 104th nationwide, will open on April 29. Located at 3873 SW College Road, the dispensary will offer medical patients a diverse collection of cannabis products from brands including RYTHM, Dogwalkers, &Shine, Good Green, and Doctor Solomon’s. As part of RISE and Green Thumb’s ongoing commitment to supporting local communities, RISE Dispensary Ocala will donate a portion of one day’s profits to community-based organization The Bridge 4 Veterans.
By Green Thumb Industries · Via GlobeNewswire · April 28, 2025
Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
NEW HAVEN, Conn., April 28, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that management will review first quarter 2025 financial results and provide a corporate update during a live webcast on Thursday, May 1, 2025, at 8:00 a.m. ET.
By Arvinas Inc. · Via GlobeNewswire · April 28, 2025
Barrick Gold Corporation Plans to Change Name to BARRICK MINING CORPORATION
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) (“Barrick” or the “Company”) today announced that it plans to change its name to Barrick Mining Corporation and from « Société aurifère Barrick » to « Société minière Barrick » in French, subject to shareholder approval at its upcoming Annual and Special Meeting of Shareholders on May 6, 2025.
By Barrick Gold Corporation · Via GlobeNewswire · April 28, 2025
SWTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SpringWorks Therapeutics, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) to Merck KGaA, Darmstadt, Germany for $47.00 per share in cash is fair to SpringWorks shareholders.
By Halper Sadeh LLC · Via Business Wire · April 28, 2025
ENI Reshapes Enterprise Blockchain: From High Performance to Global Trust
At the TEAMZ 2025 Web3/AI Summit in Tokyo, ENI showcased its enterprise blockchain innovations. As a ZK-driven modular ecosystem, its new high-performance Layer 1 architecture achieves 10,000 TPS throughput. A three-layer composite consensus mechanism, combined with a ZK coprocessor, addresses traditional blockchain pain points in performance, privacy, and scalability. This provides secure and efficient solutions for scenarios like cross-border trade, reshaping the global commercial trust network.
Via Binary News Network · April 28, 2025
Fashion to Fine Wines & Spirits: Ryder Customers Share “Stories from the Supply Chain” in National TV Ad Campaign
Ryder System, Inc. (NYSE: R) launches a national television ad campaign, “Stories from the Supply Chain,” showcasing real businesses navigating logistics challenges in an ever-shifting supply chain environment. From fashion to fine wines and spirits, the initial campaign highlights two Ryder customers – Mugsy and Southern Glazer’s Wine & Spirits – candidly recounting the moments they realized it was time to call the supply chain experts.
By Ryder System, Inc. · Via Business Wire · April 28, 2025
Roper Technologies announces first quarter financial results
Increasing full year guidance
By Roper Technologies, Inc. · Via GlobeNewswire · April 28, 2025
CoinW Strengthens Global Presence at Paris Blockchain Week 2025, Launches Strategic Hackathon with Solana
At Paris Blockchain Week 2025, CoinW expanded its international presence and strengthened industry ties through strategic engagements and sponsorships. The platform partnered with Solana to launch a four-week Super Team Hackathon focused on DeFi and DePIN, supporting blockchain developers with mentorship and resources. This initiative highlights CoinW’s commitment to fostering innovation and ecosystem growth in the global blockchain community.
Via Binary News Network · April 28, 2025
CoinW’s WConnect x Sui Season Finale Charts Roadmap to Accelerate Ecosystem Growth
CoinW and the Sui Foundation wrapped up their month-long WConnect x Sui Season with a Twitter Space event focusing on Sui’s technology, ecosystem expansion, and market strategies. Featuring experts from Mysten Labs and CoinW, the discussion highlighted Sui’s innovations and CoinW’s efforts to support blockchain developers through WConnect. The initiative aims to foster collaboration and accelerate growth in the Web3 ecosystem.
Via Binary News Network · April 28, 2025
Scholar Rock Appoints David L. Hallal as Chief Executive Officer; Also Announces Addition of Three Key Leaders to Scale for Next Phase of Growth
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for neuromuscular diseases, cardiometabolic disorders, and other serious diseases, announced today that David Hallal has been appointed Chief Executive Officer succeeding Jay Backstrom, M.D. David Hallal has served as Chairman of the Board at Scholar Rock since 2017 and just prior to that spent more than a decade as CEO, COO, and CCO of Alexion building and leading the company’s 50-country operating platform. As part of this planned transition, Dr. Backstrom will serve as a strategic advisor, working closely with the company’s executive team and Board of Directors.
By Scholar Rock · Via Business Wire · April 28, 2025
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
- NDA submitted for the treatment of central diabetes insipidus -- Expected 10-month review; commercial preparations underway for a potential Q1 2026 launch –
By Eton Pharmaceuticals · Via GlobeNewswire · April 28, 2025
Arvinas Shares New Preclinical Combination Data for the PROTAC BCL6 Degrader, ARV-393, at the 2025 American Association for Cancer Research Annual Meeting
– ARV-393 demonstrated strong synergistic antitumor activity, including complete regressions, in combination with standard-of-care chemotherapy, biologics, and select investigational oral small molecule inhibitors –
By Arvinas Inc. · Via GlobeNewswire · April 28, 2025
Rithm Property Trust Inc. Announces First Quarter 2025 Results
Rithm Property Trust Inc. (NYSE: RPT, “Rithm Property Trust” or the “Company”) today announced the following information for the quarter ended March 31, 2025.
By Rithm Property Trust Inc. · Via Business Wire · April 28, 2025
BankUnited, Inc. Reports First Quarter 2025 Results
BankUnited, Inc. (the “Company”) (NYSE: BKU) today announced financial results for the quarter ended March 31, 2025.
By BankUnited, Inc. · Via Business Wire · April 28, 2025
Lindsay Corporation to Present at the Gabelli Funds 16th Annual Value Investor Conference
Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today announced that Randy Wood, President and Chief Executive Officer, and Brian Ketcham, Senior Vice President and Chief Financial Officer, will present on an investment panel at the Gabelli Funds 16th Annual Value Investor Conference, being held May 2nd at The Hilton Omaha in Omaha, NE.
By Lindsay Corporation · Via Business Wire · April 28, 2025
2025 Global AI + Blockchain Innovation Summit: AIX Global Launch Conference, Leading the Future of Smart Finance
The 2025 Global AI + Blockchain Industry Innovation Summit and AIX Global Launch Conference concluded successfully, marking a significant step forward for the next generation of digital financial infrastructure. The summit, themed “Empowering New Finance with Intelligent Technology, A New Era of Blockchain,” gathered top global technology leaders, investment institutions, industry experts, and media representatives. They collectively explored the cutting-edge trends in the integration of AI and blockchain and witnessed the global launch of AIX, the world’s first Web3 ecosystem platform driven by AI Agents.
Via Binary News Network · April 28, 2025
Blue Sky Scrubs Honors National Nurses Week with Free Scrub Cap Giveaway
In celebration of National Nurses Week, kicking off Monday, May 6, 2025, Blue Sky Scrubs is launching a heartfelt giveaway to honor the incredible nurses and healthcare workers who care for our communities every day. The luxury scrub apparel brand is giving away 100 free scrub caps—no purchase required—as a small token of appreciation for their big impact.
Via Binary News Network · April 28, 2025
BYDFi Lists SIGN/USDT Trading Pair with $5,000 Prize Pool
VICTORIA, Seychelles, April 28, 2025 (GLOBE NEWSWIRE) -- The global cryptoc exchange BYDFi officially listed the SIGN token and opened trading for the SIGN/USDT spot pair. To celebrate the launch, BYDFi has introduced a $5,000 prize pool, open to all participating traders.
By BYDFi Blockchain Limited · Via GlobeNewswire · April 28, 2025
Heliostar Delivers Strong First Quarter 2025 Results
Q1 2025 Operational and Financial HighlightsGold equivalent ounce ("GEO") production of 9,082 GEOs and sales of 8,034 GEOs for Q1...
Via Newsfile · April 28, 2025
Hyatt Extends Tender Offer For All Outstanding Ordinary Shares of Playa Hotels & Resorts N.V.
Hyatt Hotels Corporation (“Hyatt” or the “Company”) (NYSE: H), a leading global hospitality company, announced today that HI Holdings Playa B.V., an indirect wholly owned subsidiary of Hyatt (“Buyer”), has extended the offering period of its previously announced cash tender offer to purchase all of the outstanding ordinary shares of Playa Hotels & Resorts N.V. (“Playa”) (NASDAQ: PLYA) for $13.50 per share in cash, less any applicable withholding taxes and without interest. The offer is being made pursuant to the previously announced purchase agreement, dated February 9, 2025 (the “Purchase Agreement”), among Hyatt, Buyer and Playa.
By Hyatt Hotels Corporation · Via Business Wire · April 28, 2025
Perfect Corp. Reports Unaudited Financial Results for the Three Months Ended March 31, 2025
Perfect Corp. (NYSE: PERF) (“Perfect” or the “Company”), a leading artificial intelligence (“AI”) company offering AI and augmented reality (“AR”) powered solutions to beauty and fashion industries, today announced its unaudited financial results for the three months ended March 31, 2025.
By Perfect Corp. · Via Business Wire · April 28, 2025
Compass Pathways to Announce First Quarter Financial Results on May 8, 2025
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the first quarter ended March 31, 2025, and provide an update on recent developments, on May 8, 2025.
By Compass Pathfinder Limited · Via Business Wire · April 28, 2025
NEXUS Launches Ragnarok: Monster World as FirstGame on CROSS
Seoul, Seoul, Korea South, 28th Apr 2025 — NEXUS, led by CEO Henry Chang , has officially launched its first blockchain-based game, Ragnarok: Monster World , on the CROSS protocol. Developed by 0x& , the title marks a significant step forward in NEXUS’s commitment to blending renowned intellectual properties with cutting-edge blockchain technology, while delivering a seamless multi-chain gaming experience.
Via Binary News Network · April 28, 2025
Dassault Aviation: Signature of the Rafale Marine contract for India
Signature of the Rafale Marine contract for India
By Dassault Aviation · Via GlobeNewswire · April 28, 2025